Teva Pharmaceutical Industries is a global drugmaker that develops, manufactures and markets generic medicines and a portfolio of specialty and branded pharmaceuticals.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Bridgewater | 56 | Added +18% | 1,326,678 | $44,947,851 | 0.2% |
| Larry Robbins / Glenview | 58 | Trimmed -24% | 5,081,091 | $172,147,363 | 3.1% |
| David Einhorn / Greenlight | 44 | Trimmed -1% | 2,886,059 | $97,779,679 | 2.5% |
| Stanley Druckenmiller / Duquesne | 95 | Trimmed -74% | 624,999 | $21,175 | 0.4% |
| Steve Cohen / Point72 | 76 | Trimmed -2% | 1,564,178 | $52,994,351 | 0.1% |
| Paul Tudor Jones / Tudor | 63 | Trimmed -34% | 598,200 | $20,267,016 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-03-30 | Alan Armstrong senate | BUY | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.